Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 174

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

[ 18 F]FDG-PET is superior to [ 123 I]IBZM-SPECT for the differential diagnosis of parkinsonism

Hellwig, Sabine, Amtage, Florian, Kreft, Annabelle, Buchert, Ralph, Winz, Oliver H., Vach, Werner, Spehl, Timo S., Rijntjes, Michel, Hellwig, Bernhard, Weiller, Cornelius, Winkler, Christian, Weber, Wolfgang A., Tüscher, Oliver, Meyer, Philipp T. · 2012 · Neurology

Abstract

OBJECTIVE: Imaging of regional cerebral glucose metabolism with PET and striatal dopamine D2/D3 receptors (D2R) with SPECT improves the differential diagnosis of parkinsonism. We prospectively investigated 1) the diagnostic merits of these approaches in differentiating between Lewy body diseases (LBD; majority Parkinson disease [PD]) and atypical parkinsonian syndromes (APS); 2) the diagnostic value of [¹⁸F]fluorodeoxyglucose (FDG)-PET to differentiate among APS subgroups. METHODS: Ninety-five of 107 consecutive patients with clinically suspected APS referred for imaging were recruited. [¹⁸F]FDG-PET scans were analyzed by visual assessment (including individual voxel-based statistical maps). Based on a priori defined disease-specific patterns, patients with putative APS were differentiated from LBD (first level) and allocated to the subgroups multiple system atrophy (MSA), progressive supranuclear palsy (PSP), or corticobasal degeneration (CBD) (second level). [¹²³I] iodobenzamide (IBZM)-SPECT datasets were subjected to an observer-independent regions-of-interest analysis to assess striatal D2R availability. Movement disorder specialists made final clinical diagnoses after a median follow-up time of 12 months. RESULTS: Seventy-eight patients with clinically verified APS (n = 44) or LBD (n = 34) were included in the statistical analysis. The area under the receiver operating characteristic curve for discrimination between APS and LBD was significantly larger for [¹⁸F]FDG-PET (0.94) than for [¹²³I]IBZM-SPECT (0.74; p = 0.0006). Sensitivity/specificity of [¹⁸F]FDG-PET for diagnosing APS was 86%/91%, respectively. Sensitivity/specificity of [¹⁸F]FDG-PET in identifying APS subgroups was 77%/97% for MSA, 74%/95% for PSP, and 75%/92% for CBD. CONCLUSIONS: The diagnostic accuracy of [¹⁸F]FDG-PET for discriminating LBD from APS is considerably higher than for [¹²³I]IBZM-SPECT. [¹⁸F]FDG-PET reliably differentiates APS subgroups.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e31826c1b0a

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 174

Metadata

Authors
Hellwig, S., Amtage, F., Kreft, A., Buchert, R., Winz, O. H., Vach, W., Spehl, T. S., Rijntjes, M., Hellwig, B., Weiller, C., Winkler, C., Weber, W. A., Tüscher, O., & Meyer, P. T.
Venue
Neurology
Published
2012-09-25
Volume
79
Issue
13
Pages
1314-1322
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2088292384
Cited by
174
References
5
FWCI
8.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: [ 18 F]FDG-PET is superior to [ 123 I]IBZM-SPECT for the differential diagnosis of parkinsonism. https://app.cochat.ai/papers/10.1212/wnl.0b013e31826c1b0a
The paper
Hellwig, S., Amtage, F., Kreft, A., Buchert, R., Winz, O. H., Vach, W., Spehl, T. S., Rijntjes, M., Hellwig, B., Weiller, C., Winkler, C., Weber, W. A., Tüscher, O., & Meyer, P. T. (2012). [ 18 F]FDG-PET is superior to [ 123 I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology. https://doi.org/10.1212/wnl.0b013e31826c1b0a

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.